Search filters

Filters
Clear All

Phase

  • 11
  • 38
  • 28
  • 46
  • 6
  • 50
  • 9
  • 278
  • 490
  • 158
  • 4
  • 31
  • 457
  • 486
  • 6
  • 4
  • 488

Found 492 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
Testing of Magnetic Resonance Methods at 7.0 Tesla
18 years - 60 years
All genders
Observational
The research study will test the performance of new magnetic resonance imaging and spectroscopy techniques at 7.0 Tesla. These new methods have already been tested in model systems and need to be tried on human subjects prior to use in patient population.
99 years or below
All genders
Collect safety and efficacy data of MMAE in patients ages 40-90 years with a moderately symptomatic convexity chronic subdural hematoma (CSDH). Subjects will be randomized 1:1 to conventional surgery or MMAE treatment and followed for 180 days (+/- 30 days).
99 years or below
All genders
The objective is to obtain cortical tissue that is clinically suspected to be normal brain tissue from patients undergoing epilepsy surgical resection, tumor resection, and normal pressure hydrocephalus (NPH) requiring placement of a shunt catheter. electrophysiological assays generating tissue cultures
99 years or below
All genders
The objective of this study is to obtain neural recordings from deep brain structures while performing simple intraoperative tasks in order to improve the understanding of temporal relationship of deep neural signals and the performance of simple psychomotor, cognitive, and/or executive tasks. The standard DBS surgery provides an opportunity to …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effects of adding an investigational medication to an existing treatment with ruxolitinib for patients with myelofibrosis. The purpose of this study is to determine if the investigational medication can provide more benefits than ruxolitinib alone for patients who have not responded well to ruxolitinib by itself.Participants …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates the use of an investigational medication in patients with advanced solid tumors, specifically focusing on its effects as a single agent or in combination with other therapies. The purpose is to determine the recommended Phase II dose and to evaluate its safety, tolerability, and anti-tumor activity. The …
18 years or above
All genders
Phase 2
Interventional
This study investigates the combination of an investigational medication, administered as telomelysin (OBP-301), with pembrolizumab in patients with advanced or metastatic gastric or gastroesophageal junction cancer. The purpose of this study is to determine if this combination is safe and effective for patients whose cancer has progressed despite previous treatments.Participants …
99 years or below
All genders
Primary Objective 1. To explore genetic, proteomic, and molecular characteristics associated with recurrence less than six months following completion of frontline adjuvant combination platinum-based chemotherapy versus recurrence 18 months following completion of frontline adjuvant combination platinum-based chemotherapy. 2. To create a biorepository of tissue and blood that will be used …
18 years - 100 years
Female
Phase 1/2
This study is divided into 2 parts (Escalation and Expansion).  Your study doctor or study staff will also let you know you in what part of the study you will participate.The purpose of Part 1 (Escalation) of the study is to find the highest, safe dose of the study drug(s), …
99 years or below
All genders
PURPOSE We would like to accrue patients consecutively over a several year period in order to collect tissue from many histopathologic subsets of nervous system tumors. Primary brain tumors occur nationally at a rate of approximately 17,000 new cases annually and within this group there are numerous subtypes. At the …
251 - 260 of 492